ArticleSurgical neurology international2026
Solitary left frontotemporal neuroendocrine metastasis mimicking a high-grade astrocytoma.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Brain metastases with neuroendocrine differentiation are rare but well-documented and may closely mimic primary intracranial neoplasms. Their radiological and clinical overlap with high-grade glial tumors can complicate the initial diagnostic approach, particularly in young patients without a known primary malignancy. Accurate diagnosis is critical, as neuroendocrine tumors (NETs) require systemic evaluation and management strategies distinct from those of primary brain tumors. Case Description: A 22-year-old man presented with a first-time generalized tonic-clonic seizure accompanied by severe headache, generalized weakness, malaise, and progressive right-sided facial paresis and paresthesias, later extending to the right upper extremity. Brain magnetic resonance imaging demonstrated a left frontotemporal lesion with imaging characteristics suggestive of a high-grade astrocytoma. The patient underwent surgical resection via an extended pterional approach, achieving gross total resection of the lesion. Initial histopathological evaluation suggested a high-grade glioma. However, further immunohistochemical analysis of the solid tumor component revealed positivity for pancytokeratin (AE1/AE3), MOC31 (polyclonal), and synaptophysin (polyclonal), with a Ki-67 (MIB-1) labeling index of 10-15%. These findings supported a diagnosis of carcinoma with neuroendocrine differentiation, contradicting the initial presumptive diagnosis of a primary glial tumor. A postoperative octreotide scintigraphy (octreoscan) failed to identify a primary NET. Conclusion: This case underscores the diagnostic challenge posed by brain metastases with neuroendocrine differentiation, particularly in young patients presenting with solitary intracranial lesions mimicking high-grade gliomas. It highlights the indispensable role of immunohistochemistry in establishing the correct diagnosis and guiding appropriate systemic evaluation and management. Awareness of this rare entity is essential, as misclassification may lead to suboptimal treatment strategies and delayed oncological workup.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.